Private Market View

Yizheng Biotechnology

Suzhou, China · Founded 2021 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include YuanBio Venture Capital, Wanchuang Huahui Investment Management, Beauty Answers, CDH Shanghai Dinghui Bai Fu Wealth Management.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 4 names
  • ·Watchlist + deal alerts for Yizheng Biotechnology
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Yizheng Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Yizheng Biotechnology

Developer and Manufacturer of medical devices intended to improve medical efficiency. The company develops both first-class and second-class medical devices, providing health industry users with equipment solutions.

Sector
Healthcare
HQ
Suzhou, China
Founded
2021
Ownership
Privately Held (backing)
PA Mark — not yet priced

Yizheng Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Yizheng Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Yizheng Biotechnology in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.